GPT and metabolic dysfunction-associated steatotic liver disease: At that time, it was assumed that reference populations for measuring ULN of ALT included many asymptomatic patients with nonalcoholic fatty liver disease (NAFLD), so calculating ALT levels has not been performed in healthy populations.